20 articles
A randomized trial shows that extending overnight fasting by 3 hours, timed to sleep, cuts nighttime heart rate and improves glucose control.
New study shows fasted morning resistance training produces more consistent glucose responses than fed afternoon sessions.
New research reveals specific brain cells critical for maintaining body temperature when food is restricted, with major implications for fasting safety.
New research reveals fatty liver disease follows circadian patterns linked to insulin resistance and reduced nighttime insulin availability.
New study reveals behavioral diet therapy improves glucose metabolism better than gastric bypass surgery despite equal weight loss.
HDM1002, an oral GLP-1 receptor agonist, achieved significant weight loss with manageable side effects in overweight Chinese adults.
New study shows dairy proteins combined with structured eating schedule enhances circadian rhythms and glucose control in diabetics.
A 60-week RCT finds semaglutide 2.4 mg sustains ~240 kcal/day reduction even after appetite benefits diminish.
Researchers discover how disrupted circadian rhythms in fat cells impair mitochondrial function, leading to metabolic syndrome.
New research reveals how the popular weight loss drug semaglutide works differently across three phases of treatment.
A novel mathematical model using deuterium MRI shows gastric bypass redirects nearly all ingested glucose through the liver, with more peripheral disposal.
Simple sugar supplement dramatically improved diabetes symptoms in mice by stopping inflammatory cells from releasing disease-causing particles.
Restoring mitochondrial complex I function in fat cells prevents obesity-related metabolic dysfunction, even without weight loss.
A mouse study reveals how aging and poor diet synergistically disrupt liver thyroid hormone metabolism, accelerating fatty liver disease — and why resmetirom may help.
Comprehensive therapy combining Western medicine, traditional Chinese medicine, and lifestyle changes reversed diabetes in majority of patients.
Phase 3 trial shows once-weekly mazdutide injections led to significant weight loss with minimal side effects in overweight Chinese adults.
A 6-month AI-driven personalized diet intervention cut BMI by 33% and reduced biological age by 8 years in morbidly obese patients.
Combining cold exposure with exercise activates a key metabolic pathway to reduce liver fat and fibrosis more effectively than either intervention alone.
Scientists discover how FGF21 fights liver disease through a key protein, opening new treatment paths for metabolic dysfunction.
New analysis finds delayed stomach emptying accounts for only 4–6% of appetite suppression from liraglutide, challenging a popular assumption.
